Endothelial system dysregulation underlies keloid development and therapeutic targeting. [PDF]
Yu Y, Zhu J, Ma L, Zhang X, Yan H.
europepmc +1 more source
The Translational Value of Preclinical Research: Lessons from More Than Forty Years of Retinal Research. [PDF]
Bagnoli P.
europepmc +1 more source
Exerkines During Pregnancy: Linking Maternal Exercise with Cardiometabolic Health-A Narrative Review. [PDF]
Sklempe Kokic I +4 more
europepmc +1 more source
Heparan Sulfate, Chondroitin Sulfate, and Keratan Sulfate as Regulators of Tumor Malignancy. [PDF]
Ohkawa Y, Taniguchi N.
europepmc +1 more source
Targeting vascular inflammation and endothelial dysfunction with nanobodies: emerging therapeutic strategies for cardiovascular disease. [PDF]
Aljaezi I.
europepmc +1 more source
Fibrotic Remodeling in Retinal Vascular Diseases: Cellular Origins, Molecular Mechanisms, and Therapeutic Perspectives. [PDF]
Ning JY, Wang B, Yamamoto MI, Yamada KH.
europepmc +1 more source
Related searches:
Vascular Endothelial Growth Factor and its Receptors
Retina, 1994Vascular endothelial growth factor (VEGF) is a highly specific mitogen for vascular endothelial cells and an angiogenic factor that is structurally related to platelet derived growth factor (PDGF). It is also known as the vascular permeability factor (VPF) because it efficiently potentiates the permeabilization of blood vessels. Five types of VEGF mRNA
G, Neufeld +4 more
openaire +2 more sources
Vascular endothelial growth factor and its receptors
Cytokine & Growth Factor Reviews, 1996Vascular endothelial growth factor (VEGF) is a prime regulator of endothelial cell proliferation, angiogenesis, vasculogenesis and vascular permeability. Its activity is mediated by the high affinity tyrosine kinase receptors, KDR/Fik-1 and Fit-1. In this article, recently discovered structural, molecular and biological properties of VEGF are described.
M, Klagsbrun, P A, D'Amore
openaire +2 more sources

